Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
KORE Group | KORE | Nov 1, 2024 | 1.98 | -3.41 |
Korea Electric Power ADR | KEP | Nov 1, 2024 | 8.29 | -0.72 |
Korea Fund | KF | Nov 1, 2024 | 21.55 | +1.03 |
Korn Ferry | KFY | Nov 1, 2024 | 70.65 | 0.00 |
Kornit Digital | KRNT | Nov 1, 2024 | 23.03 | +0.61 |
Korro Bio | KRRO | Nov 1, 2024 | 58.16 | +1.15 |
KORU Medical Systems | KRMD | Nov 1, 2024 | 2.70 | -7.53 |
Kosmos Energy | KOS | Nov 1, 2024 | 3.68 | -2.13 |
Koss | KOSS | Nov 1, 2024 | 7.04 | -1.40 |
Kraft Heinz | KHC | Nov 1, 2024 | 33.49 | +0.09 |
KraneShares Bosera MSCI China A ETF | KBA | Nov 1, 2024 | 24.84 | +0.16 |
Kraneshares Csi China Internet | KWEB | Nov 1, 2024 | 32.16 | -0.12 |
Kratos Defense & Security Solutions | KTOS | Nov 1, 2024 | 22.87 | +0.66 |
Krispy Kreme | DNUT | Nov 1, 2024 | 11.53 | +1.41 |
Kroger | KR | Nov 1, 2024 | 56.57 | +1.43 |
Kronos Bio | KRON | Nov 1, 2024 | 0.99 | +2.06 |
Kronos Worldwide | KRO | Nov 1, 2024 | 11.52 | -0.17 |
Krystal Biotech | KRYS | Nov 1, 2024 | 176.39 | +2.24 |
KT ADR | KT | Nov 1, 2024 | 15.72 | -0.06 |
Kuke Music ADR | KUKE | Nov 1, 2024 | 0.60 | -14.63 |
Kulicke and Soffa Industries | KLIC | Nov 1, 2024 | 45.58 | +1.61 |
KULR Technology Group | KULR | Nov 1, 2024 | 0.28 | +0.58 |
Kura Oncology | KURA | Nov 1, 2024 | 16.88 | +0.96 |
Kura Sushi USA A | KRUS | Nov 1, 2024 | 99.81 | -0.01 |
KVH Industries | KVHI | Nov 1, 2024 | 4.60 | -0.65 |
KWESST Micro Systems | KWE | Nov 1, 2024 | 0.93 | -0.11 |
Kymera Therapeutics | KYMR | Nov 1, 2024 | 46.47 | +0.65 |
Kyndryl | KD | Nov 1, 2024 | 22.97 | +0.35 |
Kyverna Therapeutics | KYTX | Nov 1, 2024 | 4.89 | +2.30 |
L.B. Foster | FSTR | Nov 1, 2024 | 19.04 | +1.01 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.